rs1060504781
Variant names:
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_001492.6(GDF1):c.537G>A(p.Gly179Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000284 in 1,161,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000034 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000028 ( 0 hom. )
Consequence
GDF1
NM_001492.6 synonymous
NM_001492.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.504
Publications
0 publications found
Genes affected
GDF1 (HGNC:4214): (growth differentiation factor 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. Studies in rodents suggest that this protein is involved in the establishment of left-right asymmetry in early embryogenesis and in neural development in later embryogenesis. The encoded protein is translated from a bicistronic mRNA that also encodes ceramide synthase 1. Mutations in this gene are associated with several congenital cardiovascular malformations. [provided by RefSeq, Jul 2016]
CERS1 (HGNC:14253): (ceramide synthase 1) This gene encodes a ceramide synthase enzyme, which catalyzes the synthesis of ceramide, the hydrophobic moiety of sphingolipids. The encoded enzyme synthesizes 18-carbon (C18) ceramide in brain neurons. Elevated expression of this gene may be associated with increased longevity, while decreased expression of this gene may be associated with myoclonus epilepsy with dementia in human patients. This protein is transcribed from a monocistronic mRNA as well as a bicistronic mRNA, which also encodes growth differentiation factor 1. [provided by RefSeq, Jul 2016]
CERS1 Gene-Disease associations (from GenCC):
- progressive myoclonic epilepsy type 8Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 19-18869179-C-T is Benign according to our data. Variant chr19-18869179-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 416262.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.504 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GDF1 | NM_001492.6 | c.537G>A | p.Gly179Gly | synonymous_variant | Exon 8 of 8 | ENST00000247005.8 | NP_001483.3 | |
| CERS1 | NM_021267.5 | c.*806G>A | 3_prime_UTR_variant | Exon 8 of 8 | ENST00000623882.4 | NP_067090.1 | ||
| GDF1 | NM_001387438.1 | c.537G>A | p.Gly179Gly | synonymous_variant | Exon 5 of 5 | NP_001374367.1 | ||
| CERS1 | NM_001387440.1 | c.*1398G>A | 3_prime_UTR_variant | Exon 7 of 7 | NP_001374369.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 4AN: 148458Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
4
AN:
148458
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00160 AC: 1AN: 626 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
626
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000276 AC: 28AN: 1013376Hom.: 0 Cov.: 29 AF XY: 0.0000310 AC XY: 15AN XY: 483372 show subpopulations
GnomAD4 exome
AF:
AC:
28
AN:
1013376
Hom.:
Cov.:
29
AF XY:
AC XY:
15
AN XY:
483372
show subpopulations
African (AFR)
AF:
AC:
1
AN:
19492
American (AMR)
AF:
AC:
0
AN:
5562
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
10274
East Asian (EAS)
AF:
AC:
0
AN:
16528
South Asian (SAS)
AF:
AC:
0
AN:
25518
European-Finnish (FIN)
AF:
AC:
0
AN:
17900
Middle Eastern (MID)
AF:
AC:
0
AN:
2460
European-Non Finnish (NFE)
AF:
AC:
26
AN:
877828
Other (OTH)
AF:
AC:
1
AN:
37814
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000337 AC: 5AN: 148566Hom.: 0 Cov.: 33 AF XY: 0.0000414 AC XY: 3AN XY: 72440 show subpopulations
GnomAD4 genome
AF:
AC:
5
AN:
148566
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
72440
show subpopulations
African (AFR)
AF:
AC:
1
AN:
41214
American (AMR)
AF:
AC:
0
AN:
14960
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3402
East Asian (EAS)
AF:
AC:
0
AN:
5132
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
9196
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
4
AN:
66566
Other (OTH)
AF:
AC:
0
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 15, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.